Embrella Cardiovascular logo — Developing advanced systems to enhance cerebral protection a...

Embrella Cardiovascular

Developing advanced systems to enhance cerebral protection and minimize embolic strokes during cardiovascular procedures, based in Malvern, Pennsylvania.

Founded 2007 Series B Total: $9.00M Health Care, Medical Devices

General Information

Company Name Embrella Cardiovascular
Founded Year 2007
Industries Health Care, Medical Devices
Funding Stage Series B
Social

Get notified when Embrella Cardiovascular moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Embrella Cardiovascular

Embrella Cardiovascular is a health care startup, founded in 2007, that focuses on developing advanced systems to enhance cerebral protection and minimize embolic strokes during cardiovascular procedures. Based in Malvern, Pennsylvania, the company has garnered significant support, with a $1.60M Series B investment announced on 01 October 2009. Notably, this investment was made by a consortium of prominent investors including Edwards Lifesciences, Hatteras Venture Partners, BioStar Capital, and MedFocus Fund. Embrella Cardiovascular's dedication to addressing a critical aspect of cardiovascular care, coupled with strong investor backing, positions the company as a highly promising player in the health care industry.

Taxonomy: Cardiovascular Health, Cerebral Protection, Interventional Cardiology, Stroke Prevention, Embolism, Medical Technology, Innovative Healthcare, Cardiovascular Procedures, Malvern, Pennsylvania, Biomedical Engineering, Medical Innovations, Investment Opportunities

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 4
Investor Investor Investor Investor
01 Oct 2009
Series B •••••• - 06 Jul 2009
Series A •••••• - 15 Jan 2008

Embrella Cardiovascular Alternatives & Competitors

Embrella Cardiovascular vs

Empowering seamless integration of top cardiology practices into a unified cardiovascular solution

Debt Financing
24 employees
Health Care
Embrella Cardiovascular vs

Advancing cardiovascular health with innovative small molecule therapeutics for unmet medical needs.

Series D
Biopharma, Biotechnology
Embrella Cardiovascular vs

Advancing Cardiovascular Ultrasound To Improve Lives.

7 employees
Health Care

FAQ About Embrella Cardiovascular

Developing advanced systems to enhance cerebral protection and minimize embolic strokes during cardiovascular procedures, based in Malvern, Pennsylvania.
Embrella Cardiovascular was founded in 2007.
Embrella Cardiovascular operates in the following industries: Health Care, Medical Devices.
Embrella Cardiovascular has completed 3 funding rounds, raising a total of $9.00M. The latest funding stage is Series B.
Top alternatives and competitors to Embrella Cardiovascular include Cardiovascular Logistics, Myogen, American Society of Echocardiography, Imageens, Khloris Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Embrella Cardiovascular and Cardiovascular Logistics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Embrella Cardiovascular and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy